摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2-吡啶-2-基乙烯基)吡嗪 | 66806-43-7

中文名称
2-(2-吡啶-2-基乙烯基)吡嗪
中文别名
——
英文名称
1-(2-Pyrazinyl)-2-(2-pyridyl)-ethen
英文别名
2-(β-(2-Pyridyl)-vinyl)-pyrazin;2-(2-pyridin-2-yl-vinyl)-pyrazine;2-[2-(Pyridin-2-yl)ethenyl]pyrazine;2-(2-pyridin-2-ylethenyl)pyrazine
2-(2-吡啶-2-基乙烯基)吡嗪化学式
CAS
66806-43-7
化学式
C11H9N3
mdl
——
分子量
183.213
InChiKey
ULTVDQOYJMXUCZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    38.7
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • Anti-Angiogenic Compounds
    申请人:UNIVERSITY COLLEGE DUBLIN - NATIONAL UNIVERSITY OF IRELAND, DUBLIN
    公开号:US20160326122A1
    公开(公告)日:2016-11-10
    Compounds and compositions are described which are useful especially for treatment of angiogenesis-related diseases or disorders such as neovascularisation of the eye, age-related macular degeneration, diabetic retinopathy or cancer.
    描述了一些化合物和组合物,特别适用于治疗与血管生成相关的疾病或疾病,如眼部新血管生成、老年性黄斑变性、糖尿病性视网膜病变或癌症。
  • [EN] ANTI-ANGIOGENIC COMPOUNDS<br/>[FR] COMPOSÉS ANTIANGIOGÉNIQUES
    申请人:UNIV DUBLIN
    公开号:WO2015107122A1
    公开(公告)日:2015-07-23
    Compounds of the formula A-X-Y-B and compositions are described which are useful especially for treatment of angiogenesis-related diseases or disorders such as neovascularisation of the eye, age- related macular degeneration, diabetic retinopathy or cancer, wherein A is a six membered heteroaryl ring containing 2 nitrogen atoms which is optionally substituted with R1; R1 is H, CI-6 alkyl, CN, CONR2R3; R2 and R3 which may be the same or different and selected from H, CI-6 alkyl or R2 and R3 form a ring; the group X-Y is an alkyne or alkene, in the case wherein X-Y is an alkene the double bond may be cis or trans and optionally substituted with R1 B is an aryl; or five or six membered heteroaryl ring containing 1 to 3 heteroatoms, both of which may optionally substituted with one or more R4; R4 is R1 or OR5; R5 is H, COR6 or R6; and R6 is CI-6 alkyl and salts thereof.
    描述了化合物A-X-Y-B的结构式和组成物,这些化合物特别适用于治疗与血管生成相关的疾病或疾病,如眼部新血管生成、年龄相关性黄斑变性、糖尿病性视网膜病变或癌症,其中A是一个含有2个氮原子的六元杂环芳基环,可选择地取代为R1;R1为H、CI-6烷基、CN、CONR2R3;R2和R3可以相同也可以不同,选择自H、CI-6烷基或R2和R3形成环;X-Y是炔烃或烯烃,如果X-Y是烯烃,则双键可以为顺式或反式,并可选择地取代为R1;B是芳基;或含有1至3个杂原子的五元或六元杂环芳基环,两者均可选择地取代为一个或多个R4;R4为R1或OR5;R5为H、COR6或R6;R6为CI-6烷基及其盐。
  • ANTI-ANGIOGENIC COMPOUNDS
    申请人:University College Dublin National University Of Ireland, Dublin
    公开号:EP3094625A1
    公开(公告)日:2016-11-23
  • US9975860B2
    申请人:——
    公开号:US9975860B2
    公开(公告)日:2018-05-22
查看更多